Hers vs Willow: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Willow beats Hers overall, scoring 8.2/10 vs 7.3/10. Willow is more affordable at $299/mo vs $348/mo. Choose Hers for women who want glp-1 access from a well-known, publicly trad. Choose Willow for users who want a balance of quality care and reasonable pric.
A side-by-side comparison of Hers and Willow covering pricing, scores, medication types, insurance, and more to help you decide.
Hers
#33 of 40The women's health arm of Hims & Hers Health (NYSE: HIMS), offering compounded GLP-1 medications with a polished app experience designed for women's health needs.
Visit HersWillow
#8 of 40Personalized GLP-1 weight loss with ongoing clinical support. The highest verified conversion rate among comprehensive care platforms.
Visit Willow| Feature | Hers | Willow |
|---|---|---|
| Our Score | 7.3/10 | 8.2/10 |
| Starting Price | $348/mo | $299/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Women who want GLP-1 access from a well-known, publicly traded telehealth brand | Users who want a balance of quality care and reasonable pricing |
| Ranking | #33 | #8 |
Pros & Cons Compared
Hers
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Women-focused branding, content, and support — not a men's health platform with a women's tab
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Broader women's health platform — can address hormonal, skin, and wellness needs alongside weight loss
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Willow
Pros
- +Includes monthly provider check-ins and dose adjustments at no extra cost
- +Switch between brand-name and compounded mid-treatment without restarting
- +$160/mo all-in — no consultation fees, no shipping charges, no lab surcharges
- +90%+ patient retention rate after 3 months per their published outcomes data
Cons
- −Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
- −Founded in 2024 — less track record than Ro or Hims, though growth has been fast
Our Verdict
Willow edges out Hers with a score of 8.2/10 vs 7.3/10. If budget is your priority, Willow starts at $299/mo compared to Hers's $348/mo. Willow offers both brand-name and compounded medications, giving you more flexibility. Choose Hers if you want: women who want glp-1 access from a well-known, publicly traded telehealth brand. Choose Willow if you want: users who want a balance of quality care and reasonable pricing.